Showing results (1681-1690 of 1,805) with videos related to

Sort By:
Pageof 181
Science Immunology|April 22, 2018
Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytesTeresita L Arenzana, Steve Lianoglou, Akiko Seki, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2018
Genotype-Phenotype Relations for the Parkinson's Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic ReviewMeike Kasten, Corinna Hartmann, Jennie Hampf, et al.
Cell|August 30, 2008
Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodiesKim Newton, Marissa L Matsumoto, Ingrid E Wertz, et al.
American Journal of Human Genetics|November 15, 2011
A fatal mitochondrial disease is associated with defective NFU1 function in the maturation of a subset of mitochondrial Fe-S proteinsAleix Navarro-Sastre, Frederic Tort, Oliver Stehling, et al.
Bioorganic & Medicinal Chemistry|December 20, 2011
Discovery of pyrazolo[1,5-a]pyridines as p110α-selective PI3 kinase inhibitorsJackie D Kendall, Patrick D O'Connor, Andrew J Marshall, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 3, 2019
Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE-ε4/TOMM40 long poly-T repeat allele variantsInga Prokopenko, Gentaro Miyakawa, Bang Zheng, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 21, 2024
Early suppression policies protected pregnant women from COVID-19 in 2020: A population-based surveillance from the Nordic countriesReetta Varpula, Outi Äyräs, Anna J M Aabakke, et al.
Nature Metabolism|August 13, 2025
D-cysteine impairs tumour growth by inhibiting cysteine desulfurase NFS1Joséphine Zangari, Oliver Stehling, Sven A Freibert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 12, 2024
Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome-Wide Association StudyYujia Zhao, Yunjia Lai, Sirwan K L Darweesh, et al.
Pageof 181